This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Lonza Guangzhou Nansha Ltd., Lonza Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Jin She - Innovator in Protein Drug Conjugates
Introduction
Jin She is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of protein drug conjugates, holding a total of 2 patents. His work focuses on innovative methods for connecting proteins and drugs, which can have substantial implications in pharmaceutical applications.
Latest Patents
Jin She's latest patents include a method for connecting a protein and a drug to form a protein drug conjugate. This invention utilizes a specific branched linker that comprises a peptide chain derived from o-hydroxy p-amino benzylic alcohol. The peptide chain is connected to a phenyl ring via the p-amino group, while the drug is linked to the phenyl ring through the benzylic alcohol moiety. Additionally, the protein is connected to the phenyl ring via the o-hydroxy group. This innovative approach not only details the preparation of such protein-drug conjugates but also explores their pharmaceutical uses, including methods for controlling the growth of undesirable cells.
Career Highlights
Throughout his career, Jin She has worked with prominent companies such as Lonza Inc. and Lonza Guangzhou Nansha Ltd. His experience in these organizations has allowed him to refine his expertise in the development of protein drug conjugates.
Collaborations
Jin She has collaborated with esteemed colleagues, including Laurent Ducry and Bernhard Stump. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Jin She is a distinguished inventor whose work in protein drug conjugates is paving the way for new pharmaceutical solutions. His innovative methods and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile